The Company restructured its business model in 2016, closing regional treating operations to focus solely on chemical product development and manufacturing. In the ensuing months, all of its products were certified code compliant by independent third party engineering organizations. In addition, two new patent applications were filed with a third in final preparation.
"There has been a tremendous amount of work performed behind the scenes to get us to this point, and we view this new volume as proof of concept for the new business strategy. Most importantly, the business is profitable due to the robust costing and pricing models we put in place early on," Comery added.
The Company said that it expects monthly volumes to be somewhat sporadic in the near term while its channel partners load their respective distribution systems, but the company also anticipates that the period represented by April, May and June should be indicative of a longer term trend.
